157 related articles for article (PubMed ID: 3525052)
1. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
3. A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes.
Helve E; Koivisto VA; Lehtonen A; Pelkonen R; Huttunen JK; Nikkilä EA
Acta Med Scand; 1987; 221(4):385-93. PubMed ID: 3300175
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
Rodger NW; Dupre J; Canny CL; Brown WF
Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
[TBL] [Abstract][Full Text] [Related]
5. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring.
Arias P; Kerner W; Zier H; Navascués I; Pfeiffer EF
Diabetes Care; 1985; 8(2):134-40. PubMed ID: 3888562
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
[TBL] [Abstract][Full Text] [Related]
9. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic episodes during continuous subcutaneous insulin infusion: decreased frequency but increased susceptibility.
Chisholm DJ; Kraegen EW; Hewett MJ
Aust N Z J Med; 1984 Jun; 14(3):255-9. PubMed ID: 6594116
[TBL] [Abstract][Full Text] [Related]
11. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
[TBL] [Abstract][Full Text] [Related]
12. Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
Gingras V; Desjardins K; Smaoui MR; Savard V; Messier V; Haidar A; Legault L; Rabasa-Lhoret R
Acta Diabetol; 2018 Mar; 55(3):227-231. PubMed ID: 29224132
[TBL] [Abstract][Full Text] [Related]
13. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
Kobayashi T; Sawano S; Itoh T; Kosaka K
Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
[TBL] [Abstract][Full Text] [Related]
15. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
16. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
Alemzadeh R; Parton EA; Holzum MK
Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
[TBL] [Abstract][Full Text] [Related]
18. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
[TBL] [Abstract][Full Text] [Related]
19. Glucose counterregulation in type 1 diabetic patients with decreased symptoms of hypoglycemia after insulin pump treatment.
Hübinger A; Wiefels K; Ziegler D; Gries FA
Klin Wochenschr; 1991 Oct; 69(17):802-7. PubMed ID: 1762386
[TBL] [Abstract][Full Text] [Related]
20. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
